-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $55

Benzinga·09/11/2026 12:50:33
Listen to the news
UBS analyst Michael Yee initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $55.